What’s New
- UChicago Medicine Emerges as a Global Leader in Focal Therapy Treatments
- FDA grants fast track designation to HLD-0915 in mCRPC
- FDA Accepts NDA for New Formulation of PSMA PET Injection in Prostate Cancer
- Insurers’ Use of Artificial Intelligence (AI)
- Psychological Side Effects for Common Prostate Cancer Treatment Raise Concerns